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Introduction: Accurate measurement of health inequities is indispensable to track progress or to identify needs
for health equity policy interventions. A key empirical task is to measure the extent to which observed inequality
in health – a difference in health – is inequitable. Empirically operationalizing definitions of health inequity has
generated an important question not considered in the conceptual literature on health inequity. Empirical analysis
can explain only a portion of observed health inequality. This paper demonstrates that the treatment of
unexplained inequality is not only a methodological but ethical question and that the answer to the ethical
question – whether unexplained health inequality is unfair – determines the appropriate standardization method
for health inequity analysis and can lead to potentially divergent estimates of health inequity.
Methods: We use the American sample of the 2002–03 Joint Canada/United States Survey of Health and measure
health by the Health Utilities Index (HUI). We model variation in the observed HUI by demographic, socioeconomic,
health behaviour, and health care variables using Ordinary Least Squares. We estimate unfair HUI by standardizing
fairness, removing the fair component from the observed HUI. We consider health inequality due to factors
amenable to policy intervention as unfair. We contrast estimates of inequity using two fairness-standardization
methods: direct (considering unexplained inequality as ethically acceptable) and indirect (considering unexplained
inequality as unfair). We use the Gini coefficient to quantify inequity.
Results: Our analysis shows that about 75% of the variation in the observed HUI is unexplained by the model. The
direct standardization results in a smaller inequity estimate (about 60% of health inequality is inequitable) than the
indirect standardization (almost all inequality is inequitable).
Conclusions: The choice of the fairness-standardization method is ethical and influences the empirical health
inequity results considerably. More debate and analysis is necessary regarding which treatment of the unexplained
inequality has the stronger foundation in equity considerations.
Keywords: Health inequalities, Health disparities, Health inequities, Measurement, EthicsIntroduction
Inequalities and inequities in health care and health out-
comes continue to be in the center stage of health policy
in many jurisdictions. Accurate measurement of inequal-
ities and inequities is indispensable to track progress or
to identify needs for policy interventions [1,2]. Regular
reporting of health inequalities and inequities requires
ongoing data and methodological improvement. Meas-
urement of health inequities is more challenging than
that of health inequalities not only for their require-
ments for data on determinants of health [3] but also for
ethical considerations. Health inequities are a subset of* Correspondence: yukiko.asada@dal.ca
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unless otherwise stated.ethically problematic health inequalities – differences in
health –, and their measurement demands a definition
of health inequity and operationalization of the chosen
definition in the measurement exercises [4,5].
To date, no single, agreed-up definition of health inequi-
ties exists. Alternative definitions of health inequity can be
distinguished by the sources of health inequality each
classified as ethically acceptable and unacceptable. For
example, Braveman and Gruskin define health equity as
“the absence of systematic disparities in health … between
social groups who have different levels of underlying social
advantage/disadvantage” ([6], p. 254). This view thus
regards inequalities associated with social advantage as
ethically unacceptable. In contrast, equal opportunity for
health, a definition gaining popularity in the health eco-
nomics literature [7-10], considers health inequality dueThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
riginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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factors within individual control are ethically acceptable
sources of inequality.
Given that the ultimate focus of policy concern is
health inequities, a key empirical task is to measure the
extent to which observed inequality in health is inequit-
able. This requires an integration of the conceptual and
empirical literatures on health inequity [4,5,11,12]. Em-
pirically operationalizing definitions of health inequity
has generated an important question not considered in
the conceptual literature on health inequity noted above
[7,11,12]. Empirical analysis can explain only a portion
of observed health inequality. The presence of large un-
explained variation in health regression models is no
news to methodologists, who typically consider it as a
data or methodological limitation. However, in the
measurement of health inequity, a question arises as to
how we should classify unexplained health inequality –
fair or unfair. This ethical question is unavoidable in
such empirical exercises, and different answers to this
question can result in divergent health inequity results,
some of which are fundamental to health equity policy,
such as how much health inequity exists in the popula-
tion, and to what degree observed health inequality is in-
equitable. Despite potentially large policy implications,
the issue of unexplained health inequality has not re-
ceived sufficient attention in health services and popula-
tion health research and policy.
The goal of this paper is to demonstrate that the answer
to the ethical question – whether unexplained health in-
equality is unfair – determines the choice of the
standardization method and can lead to potentially diver-
gent estimates of health inequity. In the next section, we
explain how this question arises in the assessment of
health inequities and articulate how answers to this ques-
tion lead to particular methodological choices. We then
demonstrate the importance of this ethical question em-
pirically using the Joint Canada/United States Survey of
Health (JCUSH) [13], which is typical of the data available
for health inequity analysis. Our analysis shows that differ-
ent ethical judgments regarding unexplained health
inequality lead to substantial differences in estimates of
health inequity. We conclude by discussing future re-
search directions to enhance understanding of this issue.
Ethical judgments regarding unexplained health
inequality in health inequity analysis
The issue of unexplained health inequality arises in an
effort to be transparent and explicit about the definition
of health inequity when empirically measuring health in-
equity. Measuring health inequity requires individual-
level data to model variation in health at the individual
level. Assuming that we have such individual-level health
survey data, we begin by quantifying the amount ofinequality in the distribution of observed health across
individuals. We can use a univariate inequality index (e.g.,
Gini index). This provides a measure of the total amount
of health inequality in the population.
To measure health inequity, we must quantify the distri-
bution of unfair health across individuals in the population,
that is, unfair health inequality. Unfair health, however, is
not directly observable. To estimate it from observed
health, we first model variation in health. The goal is to sta-
tistically explain as much variation in health as possible
with the data at hand. This enables us to partition variation
in health into that attributable to factors considered fair, or
legitimate, sources of variation, and that attributable to fac-
tors considered unfair, or non-legitimate, source of vari-
ation. In other words, to define health inequities we need
to look at causes of health inequalities [11].
As an example, let us consider a popular definition of
health inequity, policy amenability, which argues that
health inequality due to factors amenable to policy inter-
vention is unfair [14]. We classify each variable in our data
as a legitimate (ethically acceptable) source of inequality –
that is, it is not amenable to policy intervention – or an
illegitimate (ethically unacceptable) source of inequality –
that is, it is amenable to policy intervention. Table 1 is an
example of such legitimate-illegitimate classification based
on the perspective of policy amenability. We assume age
largely represents the biological association with health
and treat it as the only variable that is not amenable to
policy intervention, and thus, a legitimate source of vari-
ation in health. We classify all other variables as amenable
to policy because: (a) it is possible to change the distribu-
tion of the variable (e.g., education, income), or (b) even
when it is not possible to change the distribution of the
variable, it is in principle possible to change how society
treats people with the characteristic (e.g., for race and sex,
it is possible to eliminate racial or sex discrimination). Age
and sex capture both biology and social policy, and the
asymmetrical treatment stems from our assumption as to
which effect each of these variables represents most.
Classifications like that in Table 1 generate intense de-
bate for at least two reasons. First, defining health inequity
in this way assumes causality between health and the
other variables, which cannot always be established empir-
ically due to data and methodological limitations. Second,
people debate passionately whether a particular source is
legitimate or illegitimate. Our particular choices presented
in Table 1 are only for illustrative purposes. The key point
here is that, to estimate unfair health, one needs to classify
variables as legitimate or illegitimate according to a
chosen definition of health inequity.
Having classified each variable, we then remove the
influence of the fair component – legitimate variables
according to a chosen definition of health inequity – on
the observed health through fairness-standardization.
Table 1 Legitimate-illegitimate classification of variables
according to the perspective of policy amenability







Country of birth Illegitimate
Health behaviour
Smoker type and history Illegitimate
BMI Illegitimate














Health insurance type Illegitimate
BMI: body mass index.
Variables are those we include in our analysis using the Joint Canada/
United States Survey of Health (JCUSH).
“Policy amenability” argues that health inequality due to factors amenable to
policy intervention is unfair [14].
A legitimate source of health inequality means that the variable is not
amenable to policy, thus, resulting health inequality is ethically acceptable.
An illegitimate source of health inequality means that the variable is amenable
to policy, thus, resulting health inequality is ethically unacceptable.
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Fairness-standardization is similar to age-standardization
in epidemiological studies, which removes the influence of
age when estimating mortality rates, but in this context,
standardization removes the influence of all legitimate
sources of inequality. Consequently, the standardization
generates the inequitable distribution of health in the
population. The amount of inequity is then quantified by
applying the same inequality index as above to this dis-
tribution of unfair health. Despite the use of the same
mathematical index, the measure here is an index of in-
equity, as opposed to simply inequality, as it quantifies
the distribution of unfair health.
For fairness-standardization, two methods are avail-
able: direct and indirect. As we show below, the choice
of the standardization method is closely connected to
ethical judgments regarding unexplained inequality.Both direct and indirect standardization methods are
based on the notion that the observed health consists of
legitimate, illegitimate, and unexplained components:
Observed HUI ¼ Legitimateþ Illegitimate
þ Unexplained
Using the direct standardization method, we predict
unfair health directly by allowing only the illegitimate
variables alone to influence the predictions. To do so,
we purge the influence of legitimate variables by setting
the value of these variables constant (expressed with the
bar in the equation) during the prediction and ignore
the unexplained component:
Unfair^ HUIdirect ¼ Legitimateþ Illegitimate
As is clear, this produces a distribution in which the
only source of variation in predicted levels of health
arises from variation across individuals in illegitimate
factors.
Using the indirect standardization, we first predict fair
health by allowing only the legitimate variables to influ-
ence the predictions. To do so, we purge the influence
of illegitimate variables (by holding their values at a con-




HUI ¼ Legitimateþ Illegitimate
We then calculate unfair health by subtracting the es-
timate of fair health from the observed health and add-
ing the mean health of the population:
Unfair^ HUI indirect
¼ Observed HUI−Fair^HUI þ Population0s mean HUI
¼ Legitimateþ Illegitimateþ Unexplainedð Þ−Legitimate
þ Population0s mean HUI
¼ Illegitimateþ Unexplained þ Population0s mean HUI
This addition of the mean health of the population is
conventional [15] and ensures that the distributions of
the observed health and the unfair health have the same
mean value.
For both standardization methods, we can choose any
values at which to hold the relevant variables constant (le-
gitimate variables for direct standardization and illegitim-
ate for indirect standardization). But the choice reflects an
ethical and policy judgment regarding the reference attri-
butes by which we assess health inequity. For example, for
the definition of policy amenability discussed above, we
can hold each relevant variable at the category to which
policies might reasonably aim (e.g., education at “high
school”), or we could set the level to the healthiest cat-
egory in the population (e.g., education at “university or
college certificate”). Whether we should assess health
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which differences in health we consider as unfair and what
reference we consider as an appropriate policy goal.
Just as the legitimate-illegitimate classification of vari-
ables, the choice of reference values can generate de-
bate. For the purpose of this paper, which compares the
two standardization methods, we set reference values
equal to the modest goals as an example.
Importantly for the focus of this paper, notice that the
unfair health estimated by the direct standardization
does not include the unexplained component while the
unfair health estimated by the indirect standardization
does. The larger the unexplained component is, the
greater the discrepancy is between unfair health esti-
mated by these two standardization methods.
Notice further that the choice of the standardization
methods implies ethical judgments: using the direct
standardization, we regard unexplained variation in in-
equality as ethically acceptable, and using the indirect
standardization, we regard it as unfair. Although this
issue has been raised in the health economics literature
[7,11,12], there has been little appreciation for these
ethical judgments in the public health and health policy
literatures. Below we illustrate how much difference
these standardization methods can make in estimates of
health inequity using typically available survey data.Methods
Data
We estimate health inequity using the 2002–03 Joint
Canada/United States Survey of Health (JCUSH), a
cross-sectional population health survey jointly con-
ducted by Statistics Canada and the U.S. National Center
for Health Statistics [13]. The JCUSH questionnaire in-
cluded questions regarding health status, health care
utilization, health behaviour, socioeconomic status, and
health insurance status. The target population was non-
institutionalized Canadian and U.S. household residents
aged 18 and older. The JCUSH used a complex sampling
design with stratification by geographic region and over-
sampling of respondents aged 65 and over.
For simplicity and the ease of exposition, in this paper
we present the results for the American sample only.
The analysis using the Canadian sample yielded the
same key methodological findings (available from the au-
thors upon request). The original American sample of
the JCUSH is 5,183 (response rate: 50.2%). We exclude
observations with missing values (typically less than 4%
of observations), except income (19.8%), for which we
create “income missing” category. We also exclude 48
observations with scores of the Health Utilities Index
(HUI), our measure of health, less than or equal to zero.
The final sample size for our analysis is 4,328.Variables
Health
We measure health by the Health Utilities Index Mark 3
(HUI), a well validated and widely used generic health-
related quality of life measure [16]. The HUI measures
the respondent’s functional levels in eight dimensions
(vision, hearing, speech, mobility, dexterity, emotion,
cognition, and pain) and converts his or her functional
levels into a health-related quality-of-life score based on
preferences of the general public (as opposed to the re-
spondent’s preferences) over health states. One advan-
tage of the HUI is that it is possible to identify when a
difference in scores is meaningful for policy purposes. A
difference of 0.030 or greater is meaningful or important
[17], indicating the difference large enough to justify a
recommendation for an intervention to achieve such an
increment in health [18]. The observed distribution of
HUI scores in the full sample range from −0.360 to
1.000 on a scale in which 0.000 represents being dead
and 1.000 represents perfect health, and negative scores
indicates health states worse than dead. For our analysis,
we use only observations with zero or positive HUI
scores as the Gini index, by which we measure univari-
ate inequality and inequity, allows only non-negative
values for the variable being analyzed [19].
Attributes known to be associated with health
We use a number of attributes known to be associated
with health and available from the JCUSH: demographic
status, health behaviour, socioeconomic status, and
health care system factors, including the availability of
basic health care, quality of health care, and health care
insurance. We tested for interactions among these vari-
ables and retained the interaction terms between smoking
and income and between body mass index (BMI) and edu-
cation, which remain statistically significant at the 5% level
in the final model.
Quantifying health inequality and inequity
We use the Gini coefficient to quantify health inequality
and inequity [4,20]. The Gini coefficient takes values be-
tween zero (perfectly equal distribution) and one (most
unequal). The Gini coefficient is widely used in the in-
come inequality literature and has also been applied to
quantify the distribution of health [21]. The Gini coeffi-
cient assumes that the underlying variable is measured
at the ratio scale level. The HUI is an interval-scale
measure, so our application of the Gini to the HUI vio-
lates this assumption. In practice, however, many in-
equality analyses apply the Gini to health measures that
do not strictly satisfy this assumption, and given that the
choice of inequality measure is not central to the main
focus of our analysis, we believe our use of the Gini is rea-
sonable. Although the 0–1 index of the Gini coefficient
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value of the Gini coefficient indicates the proportion of
the expected mean difference between two randomly se-
lected persons in the population [22]. For example, a value
of 0.100 for the Gini coefficient with the mean HUI, 0.800,
indicates that the expected difference in the HUI from
two randomly drawn persons in this population is twice
0.100 (i.e., 0.200) of the mean HUI, 0.800 (i.e., 0.160).
When the Gini coefficient in the population indicates the
expected difference in the HUI from two randomly drawn
persons equal to or greater than 0.030, the minimum mag-
nitude for a difference in HUI scores to be policy relevant,
we consider this inequality or inequity as policy relevant.
Analysis
The analysis proceeds with the following three steps. First,
we estimate the magnitude of inequality in the observed
HUI across individuals using the Gini coefficient. Second,
we model variation in the observed HUI. Third, based on
the definition of policy amenability, as discussed above,
and using the direct and indirect standardization methods,
we estimate unfair HUI for each individual and quantify
the magnitude of inequity using the Gini coefficient. In
both standardization methods, we hold relevant variable
at the category to which policies might reasonably aim
(see Additional file 1).
Modeling the distribution of the HUI is challenging
because the HUI is bounded (between 0.000 and 1.000),
it spikes at 1.0 (in our JCUSH sample, about 25% of the
observations have HUI=1), and it is left-skewed. Re-
searchers have recommended a number of alternative
statistical methods to empirically model the distribution
of HUI, including Ordinary Least Squares (OLS), Tobit,
censored least absolute deviation (CLAD), two-part
models, and latent class models, with no consensus re-
garding the best approach [23-26]. In this paper we
present results from the OLS because OLS performed
well relative to two-part models and CLAD in our sensi-
tivity analysis and is easier to understand than the
alternativesa.
We weight all analyses using the sample weights pro-
vided by the JCUSH. To estimate variance accounting
for the JCUSH’s complex survey design, we use the bal-
anced repeated replication methods with balanced re-
peated replication weights provided by Statistics Canada
and the US National Center for Health Statistics. We
consider p<0.05 as statistically significant. We use Stata
11 for all analyses [27,28].
Results
Sample characteristics
Sample characteristics and the average HUI across sub-
groups mostly follow expected patterns (Table 2). The
average HUI is lower among older age groups; thoseseparated, divorced, or widowed; black or other racial
group; those with unmet need; those without pharma-
ceutical insurance; and those with Medicaid only. The
average HUI does not differ much by sex or country of
birth. Those with healthy behaviours and high socioeco-
nomic status, measured by income or education, have
higher average HUI. Those with no regular medical doc-
tor and no health insurance have higher average HUI
than those with regular medical doctor and health insur-
ance, which may indicate younger age and less demand
for health care among this group. High demand for
health care may be a factor for lower average HUI
among those with high blood pressure or asthma and re-
ceived treatment or medication in the last 12 months
than those with such conditions but who did not obtain
treatment or medication.
Modeling variation in health (HUI)
The fit of our model is comparable to other work de-
scribing the variation in the HUI (adjusted R2: 0.258,
Table 3) [29,30]. Among the demographic variables, only
age is statistically significant. Lack of statistical signifi-
cance of race is somewhat counter-intuitive but confirms
other studies using the JCUSH (e.g., [30]). When we add
socioeconomic variables to demographic variables, race
becomes statistically insignificant, and, after introducing
health care supply variables, the sign of the coefficient
for black flips from negative to positive. All health be-
haviour variables (smoker type, BMI, and physical activ-
ity) and socioeconomic variables (income and education)
show statistically significant effects on the HUI, either
individually or through interactions. All health care sup-
ply variables are statistically significant, with the unmet
need variable showing the largest coefficient (−0.110),
followed by health insurance type (−0.092 for Medicaid
only with no insurance as the reference).
Health inequality
The far left data point of Figure 1 shows the magnitude of
health inequality. The Gini coefficient for the distribution
of the observed HUI is 0.094 (95% CI: 0.089, 0.100), and
the mean HUI value for this distribution is 0.880 (95%
confidence interval [CI]: 0.873, 0.886). Based on this infor-
mation, the expected mean difference in the HUI of two
randomly selected individuals is 0.165, which notably
larger than the minimally policy significant difference in
the HUI of 0.030.
Health inequity – the direct vs. indirect fairness-
standardization method
As shown in Figure 1, the choice of the standardization
method makes a substantial difference in estimates of
health inequity. Using the direct standardization, the
magnitude of health inequity, expressed by the Gini
Table 2 Sample characteristics
N (%) HUI










Married or common law partner 2,443(56.45) 0.888








Foreign born 614(14.19) 0.867
Native born 3,714(85.81) 0.869
Health behaviour
Smoker type and history
Never smoked 2,259(52.20) 0.889
Former smoker and started smoking
at or after 18 years
717(16.57) 0.858





Normal weight 1,864(43.07) 0.890
Overweight 1,455(33.62) 0.880
Obese 913(21.10) 0.813






Lowest income quintile 665(15.37) 0.769
Lower middle income quintile 696(16.08) 0.855
Middle income quintile 620(14.33) 0.894
Higher middle income quintile 726(16.77) 0.909
Highest middle income quintile 763(17.63) 0.930
Income missing 858(19.82) 0.852
Table 2 Sample characteristics (Continued)
Education
Less than high school 431(9.96) 0.756
High school graduate 1,569(36.25) 0.856
Non-university/college certificate 635(14.67) 0.867
University/college certificate 1,693(39.12) 0.911
Health care factors






With high blood pressure and received
treatment in the last 12 months
No 54(1.25) 0.820
Yes 832(19.22) 0.788
No high blood pressure 3,442(79.53) 0.889
With asthma and received
medication in the last 12 months
No 190(4.39) 0.882
Yes 280(6.47) 0.784




Health insurance type (US only)
No insurance 443(10.24) 0.851
Medicaid only 160(3.70) 0.677
Non-Medecaid public only including Medicare 254(5.87) 0.758
Private plus public including Medicare 818(18.90) 0.811
Private only 2,653(61.30) 0.912
Data source: Joint Canada/United States Survey of Health (JCUSH).
BMI: body mass index; HUI: Health Utilities Index.
BMI is based on the World Health Organization. Underweight: <18.5 kg/m2;
normal weight: 18.5-24.9 kg/m2; overweight: 25-30 kg/m2; obese >30 kg/m2.
HUI estimates are weighted and unadjusted.
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0.061), while using the indirect standardization, the Gini
coefficient is 0.086 (95% CI: 0.082, 0.091). The large differ-
ence between these inequity estimates reflects the large
amount of unexplained variation in health – the adjusted
R2 for the regression model is 0.258, which indicates that
about 75% of the variation in the observed HUI is not
explained by the model. The direct standardization
method presumes this large unexplained variation is fair,
while the indirect method regards this unexplained vari-
ation as unfair.
Both inequity estimates are policy relevant. The Gini
coefficients of 0.059 (the direct standardization) and of
Table 3 Results of ordinary least squares regression model for the health utilities index
Coefficient (95% CI) p-value
Age (years, reference: 18-44) 0.000
45-64 -0.044(-0.057, -0.030) 0.000
65+ -0.013(-0.041, 0.015) 0.362
Male -0.001(-0.012, 0.010) 0.890
Marital status (reference: single) 0.064
Married or common law partner -0.005(-0.010, 0.019) 0.554
Separated, divorced, or widowed -0.014(-0.034, 0.005) 0.155
Race (reference: White) 0.342
Other -0.006(-0.028, 0.016) 0.601
Black -0.016(-0.005, 0.037) 0.127
Asian -0.011(-0.046, 0.024) 0.546
Foreign born -0.006(-0.013, 0.026) 0.515
Smoking (reference: never smoked) 0.059
Former smoker and started smoking at or after 18 years -0.052(-0.107, 0.002) 0.060
Former smoker and started smoking before 18 years -0.086(-0.170, 0.003) 0.043
Current smoker and started smoking at or after 18 years -0.015(-0.066, 0.036) 0.558
Current smoker and started smoking before 18 years -0.070(-0.140, 0.000) 0.050
BMI (reference: normal weight) 0.053
Underweight -0.166(-0.283, 0.048) 0.006
Overweight -0.025(-0.084, 0.034) 0.402
Obese -0.086(-0.084, 0.040) 0.485
Frequency of physical activity (reference; regular) 0.000
Occasional -0.012(-0.024, 0.001) 0.069
Infrequent -0.083(-0.099, -0.066) 0.000
Household income (reference: lowest income quintile) 0.122
Lower middle income quintile -0.021(-0.009, 0.050) 0.169
Middle income quintile -0.038(-0.010, 0.067) 0.009
Higher middle income quintile -0.036(-0.008, 0.064) 0.011
Highest middle income quintile -0.037(-0.008, 0.065) 0.011
Income missing -0.027(-0.001, 0.056) 0.056
Education (reference: less than high school) 0.026
High school graduate -0.007(-0.035, 0.049) 0.737
Non-university/college certificate -0.032(-0.013, 0.078) 0.162
University/college certificate -0.029(-0.013, 0.070) 0.176
Has regular medical doctor -0.021(-0.036,-0.006) 0.005
Presence of self-reported unmet need -0.110(-0.133,-0.087) 0.000
Treatment for high blood pressure in the last 12 months (reference: no treatment) 0.000
Received treatment -0.023(-0.081, 0.034) 0.424
No high blood pressure -0.020(-0.034, 0.073) 0.475
Medication for asthma in the last 12 months (reference: no medication) 0.008
Received medication -0.020(-0.076,-0.004) 0.031
No asthma -0.000(-0.026, 0.026) 0.999
Has pharmaceutical insurance -0.032(-0.051, 0.013) 0.001
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Table 3 Results of ordinary least squares regression model for the health utilities index (Continued)
Health insurance type (US only, reference: no insurance) 0.000
Medicaid only -0.092(-0.146,-0.039) 0.001
Non-Medicaid public only including Medicare -0.052(-0.092,-0.013) 0.010
Private plus public including Medicare -0.038(-0.074, 0.001) 0.043
Private only -0.035(-0.008, 0.062) 0.010
Smoking x household income (reference: never smoked x lowest income quintile) 0.024
Former smoker and started smoking at or after 18 years
x Lower middle income quintile 0.011(-0.063, 0.085) 0.770
x Middle income quintile 0.038(-0.024, 0.101) 0.225
x Higher middle income quintile 0.050(-0.010, 0.111) 0.101
x Highest middle income quintile 0.062(0.000, 0.124) 0.050
x Income missing 0.086(-0.003, 0.122) 0.064
Former smoker and started smoking before 18 years
x Lower middle income quintile 0.041(-0.059, 0.141) 0.418
x Middle income quintile 0.062(-0.035, 0.160) 0.210
x Higher middle income quintile 0.105(0.015, 0.194) 0.023
x Highest middle income quintile 0.094(0.004, 0.184) 0.041
x Income missing -0.003(-0.110, 0.105) 0.962
Current smoker and started smoking at or after 18 years
x Lower middle income quintile 0.027(-0.035, 0.088) 0.396
x Middle income quintile -0.022(-0.085, 0.040) 0.487
x Higher middle income quintile -0.010(-0.072, 0.053) 0.757
x Highest middle income quintile 0.025(-0.033, 0.084) 0.393
x Income missing 0.002(-0.061, 0.065) 0.955
Current smoker and started smoking before 18 years
x Lower middle income quintile 0.063(-0.016, 0.142) 0.116
x Middle income quintile 0.002(-0.100, 0.103) 0.976
x Higher middle income quintile 0.027(-0.058, 0.112) 0.531
x Highest middle income quintile 0.094(-0.007, 0.180) 0.034
x Income missing 0.002(-0.041, 0.141) 0.282
BMI x education (reference: normal weight x less than high school) 0.005
Underweight
x High school graduate 0.108(-0.038, 0.255) 0.147
x Non-university/college certificate 0.159(-0.021, 0.340) 0.083
x University/college certificate 0.176(-0.052, 0.301) 0.006
Overweight
x High school graduate 0.051(-0.012, 0.113) 0.112
x Non-university/college certificate 0.014(-0.051, 0.080) 0.665
x University/college certificate 0.022(-0.040, 0.083) 0.490
Obese
x High school graduate -0.001(-0.068, 0.067) 0.985
x Non-university/college certificate -0.051(-0.128, 0.025) 0.190
x University/college certificate 0.013(-0.051, 0.078) 0.683
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Table 3 Results of ordinary least squares regression model for the health utilities index (Continued)
Constant 0.919(0.839, 1.000) 0.000
Sample size 4328
Adjusted R-squared 0.258
Data source: Joint Canada/United States Survey of Health (JCUSH).
CI: confidence interval; BMI: body mass index.
P-value for each variable category is from t-test; p-value for the reference category is from F-test for all categories of each variable.
Analysis is weighted. Standard errors are adjusted for the complex survey design.
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expected mean differences in the HUI of 0.101 and
0.166, respectively, between two randomly selected
persons. These HUI values are more than three times
larger than the minimally policy relevant difference of
the HUI, 0.030.
Health inequality vs. health inequity
Figure 1 also shows that the choice of the standardization
method influences the comparison between health in-
equality and health inequity. The Gini coefficient for the
distribution of the observed HUI (0.094; 95% CI: 0.089,
0.100) is 1.6 times larger than the Gini coefficient for
health inequity estimated by the direct standardization
(0.059; 95% CI: 0.058, 0.061). However, the Gini coeffi-
cients for inequality and for inequity estimated by the in-
direct standardization (0.086; 95% CI: 0.082, 0.091) are
not statistically significantly different. Therefore, the
choice of the standardization method offers two contrast-
ing results: About 60% of health inequality (the direct
standardization) or almost all health inequality (the indir-












Figure 1 Magnitude of health inequality and health inequity estimate
Joint Canada/United States Survey of Health (JCUSH). Analysis is weighted.
coefficient takes values between zero (most equal) and one (most unequal
variation in inequality as ethically acceptable, and the use of the indirect stDiscussion
In the context of the empirical assessments of health in-
equities, this paper investigated the empirical import-
ance of the ethical question of whether unexplained
health inequality is unfair. The classification of unex-
plained inequality as fair or unfair is closely connected
to the choice of the fairness-standardization methods, a
critical step for the measurement of health inequities. As
the analysis of the US component of the JCUSH showed,
this choice can substantially influence the empirical re-
sults regarding how much health inequity exists in the
population and the proportion of observed health in-
equality that is inequitable. We obtained the same re-
sults in analyses using the Canadian sample of the
JCUSH and using a different definition of health in-
equity, equal opportunity for health (results not shown).
The question of how best to treat unexplained health
inequality deserves more extensive consideration in the
assessment of health inequities than it currently does.
Both direct and indirect fairness-standardization
methods are technically valid but can produce different




d by the direct and indirect fairness standardization. Data source:
Standard errors are adjusted for the complex survey design. Gini
). The use of the direct standardization implicitly regards unexplained
andardization implicitly regards it as unfair.
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here may be the choice between direct and indirect age-
standardization methods in epidemiological studies [31].
Both of these methods are sound but are known to pro-
duce different results. Analysts are therefore advised to
be explicit and consistent about their methodological
choice. What complicates the choice of the fairness-
standardization methods is that it is not merely meth-
odological but ethical.
Although unexplained health inequality is not an issue
for those who subscribe to the view that all health inequal-
ities are inequitable (for whom all observed variation – ex-
plained or unexplained – is unfair), it is an unavoidable
issue for empirical analysts who do distinguish between
pure health inequality and health inequity. Currently avail-
able data and modeling techniques enable analysts to ex-
plain only a relatively small portion of observed variation
in health at the individual level. Because the issue of unex-
plained inequality only arises in empirical work, it has
rarely been paid attention to in the conceptual discussion
regarding definitions of health inequity. Still, some work
in the recent detailed philosophical analysis of health in-
equity by philosophers, economists, and ethicists provides
a hint as to how to consider the ethical significance of un-
explained inequality.
To examine the ethical significance of unexplained in-
equality, it is useful to recognize that unexplained vari-
ation – residuals in a regression context – consists of two
types of variation: variation systematically related to unob-
served factors and random variation. The issue of un-
measured systematic variation stems from methodological
limitations. Improved data, such as longitudinal data with
a rich array of variables capturing individuals’ life
history, and improved modeling techniques can reduce
unmeasured systematic variation. As soon as unmeas-
ured systematic variation becomes observed systematic
variation, the question goes back to a familiar, on-going
debate regarding definitions of health inequity, that
is, which sources of health inequality are ethically
unacceptable.
To assess the ethical significance of random variation,
the philosophical literature distinguishes “brute luck” –
unfortunate events from which even sensible persons suf-
fer, such as being hit by lightning during the commute
with no warning, or suffering from a genetic disease by
chance (often referred to as genetic lottery) – and “option
luck” – unfortunate events associated with voluntary risks,
such as being hit by lightning while playing golf with a
plenty of warning or getting injured during voluntary bun-
gee jumping [32-34]. The philosophical literature offers a
wide range of views regarding the ethical significance of
brute and option luck. Some scholars consider neither
option nor brute luck as unfair because only variations
in health associated with known socially distributeddeterminants of health are unfair [35,36]. Alternatively,
most equality in opportunity theories, also known as luck
egalitarianism, consider that inequality caused by brute
luck is unfair while that by option luck is fair [37]. Yet an-
other view sees both brute and option luck as unfair [38].
To date, this philosophical literature has not caught atten-
tion in health services and population health research and
policy, but it is an important literature in the face of large
unexplained health inequality in empirical work.
Advances in data, modeling techniques, and philosoph-
ical arguments are ongoing processes, and the measure-
ment and monitoring of health inequities for effective
policy making cannot wait for their perfection. Three pro-
posals are available for the treatment of unexplained
health inequality in the current imperfect world that still
urges policy making. First, Bago d’Uva, Jones, and van
Doorslaer [39] recommend in the context of need-
standardization for health care utilization, which faces a
directly analogous problem, that analysts always provide
two estimates of inequity, the lower bound estimate pro-
vided by the direct standardization and the upper bound
estimate by the indirect standardization. This is a prag-
matic stop-gap solution but passes the difficult ethical
question to users of health inequity information. Second,
given complex causal relationships between health and its
determinants and the fact that we do not understand them
fully, we might argue that it would be safer to assume un-
explained health inequality is of ethical significance, that
is, unfair [40,41]. This judgment, and policy decisions that
follow from it, will come with some opportunity cost. Re-
sources that are devoted to address health inequity based
on this judgment could be directed to competing health
or other social issues. We should at least know the nature
of such opportunity cost before committing to such
judgment.
Finally, Garcia-Gomez and colleagues [7] empirically
investigate what unexplained health inequality is. They
tested the view articulated by Lefranc and colleagues in
the analysis of unexplained income inequality [42]: clas-
sify unexplained inequality as luck; examine whether the
distribution of luck is uncorrelated with ethically un-
acceptable sources of inequality; and if that is the case,
consider luck an ethically acceptable source of inequal-
ity. In their analysis of inequality in mortality among the
Dutch population, they adopted the view of equal oppor-
tunity for health as the definition of health inequity, which
argues that health inequality due to factors beyond indi-
vidual control is unfair. They considered variables such as
sex, age, and education as ethically unacceptable sources
of inequality while variables such as smoking, exercise,
and weight as ethically acceptable sources of inequality.
They found that unexplained inequality is distributed dif-
ferently across groups of people categorized by sex, age,
and education with or without controlling for the health
Asada et al. International Journal for Equity in Health  (2015) 14:11 Page 11 of 12behaviour. In sum, their analysis suggests that unexplained
inequality is not an ethically acceptable source of
inequality.
Most of this emerging empirical work and its authors’
insight in into the importance of ethical discussion are of
considerable significance for public health and health pol-
icy. Given potentially serious policy implications of the
issue of unexplained health inequality, analysts should at
least make their methodological choices explicit and re-
port both results from both standardization methods
whenever they can. Moving beyond this pragmatic
solution, however, analysts need to spur more debate and
analysis regarding which treatment of the unexplained
inequality has the stronger foundation in equity
considerations.
Endnote
aThe choice of the standardization methods would be-
come even more ethically relevant if we used a non-
linear model for the HUI. This means that, in a sense,
our results using a linear model provide conservative es-
timates of the importance of this choice. We would like
to thank an anonymous reviewer for pointing this out.
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Additional file 1: Categories at which variables are held constant in
the fairness-standardization in the analysis.
Abbreviations
BMI: Body mass index; CI: Confidence intervals; CLAD: Censored least
absolute deviation; HUI: Health utilities index; JCUSH: Joint Canada/United
States Survey of Health; OLS: Ordinary least squares; US: United States.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YA conceived and designed the study and analyzed the data, and JH, OFN, and
MJ critically contributed to the conception, design, and analysis. All authors
critically contributed to interpret results. YA and JH drafted the manuscript. All
authors contributed to critical revisions of the manuscript for important
intellectual content. All authors read and approved the final manuscript.
Acknowledgements
This study was supported by Nova Scotia Health Research Foundation (8677)
and Canadian Institutes of Health Research (MPE 124739). Yukiko Asada was
supported by a Canadian Institutes of Health Research New Investigator
Award (MSH 87687). The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript. We
gratefully acknowledge valuable comments from Dan Hausman, Larry
Temkin, and participants of the polinomics seminar at the Centre for Health
Economics and Policy Analysis at McMaster University and the Quebec
Inter-University Center for Social Statistics conference: the social policy
and health inequalities: An International perspective.
Author details
1Department of Community Health and Epidemiology, Dalhousie University,
5790 University Avenue, Halifax, Nova Scotia B3H1V7, Canada. 2Department
of Economics and Centre for Health Economics and Policy Analysis,
McMaster University, Hamilton, Ontario L8S4M4, Canada. 3Department of
Research and Development, Haukeland University Hospital, Jonas Liesvei 65,5021 Bergen, Norway. 4Centre de Recherche du Centre Hospitalier de
l’Université de Montréal (CRCHUM), Tour Saint-Antoine, Porte S03-458, 850,
rue St-Denis, Montreal, Quebec H2X0A9, Canada. 5Département
d’administration de la santé, Université de Montréal, C.P. 6128, succursale
Centre-ville, Montreal, Quebec H3C3J7, Canada.
Received: 13 August 2014 Accepted: 7 January 2015
References
1. Truman BI, Smith KC, Roy K, Chen Z, Moonesinghe R, Zhu J, et al. Rationale
for regular reporting on health disparities and inequalities - United States.
MMWR Surveill Summ. 2011;60 Suppl 01:3–10.
2. WHO Commission on Social Determinants of Health. Closing the gap in a
generation: health equity through action on the social determinants of
health. Geneva: 2008. http://www.who.int/social_determinants/
thecommission/finalreport/en/index.html.
3. Bilheimer LT, Klein RJ. Data and measurement issues in the analysis of
health disparities. Health Serv Res. 2010;45:1489–507.
4. Asada Y. Health inequality: Morality and measurement. Toronto: University
of Toronto Press; 2007.
5. Braveman P. Health disparities and health equity: concepts and
measurement. Annu Rev Public Health. 2006;27:167–94.
6. Braveman P, Gruskin S. Defining equity in health. J Epidemiol Community
Health. 2003;57:254–8.
7. Garcia-Gomez P, Schokkaert E, Van Ourti T, Bago D’Uva T. Inequity in the
face of death. Core Discuss Pap. 2012;2012:46. http://www.ecore.be/DPs/
dp_1338384661.pdf.
8. Jusot F, Tubeuf S, Trannoy A. Circumstances and efforts: how important is
their correlation for the measurement of inequality of opportunity in
health? Health Econ. 2013;22:1470–95.
9. Rosa Dias P. Inequality of opportunity in health: evidence from a UK cohort
study. Health Econ. 2009;18:1057–74.
10. Trannoy A, Tubeuf S, Jusot F, Devaux M. Inequality of opportunities in
health in France: a first pass. Health Econ. 2009;19:921–38.
11. Fleurbaey M, Schokkaert E. Unfair inequalities in health and health care.
J Health Econ. 2009;28:73–90.
12. Fleurbaey M, Schokkaert E. Equity in health and health care. In: Pauly MV,
Mcguire GG, Barros PP, editors. Handbook of Health Economics, vol. 2.
Oxford: Elseview BV; 2012. p. 1003–92.
13. Statistics Canada,United States National Center for Health Statistics. Joint
Canada/United States Survey of Health: public use microdata file user guide.
Ottawa: Statistics Canada; 2004.
14. Norheim OF, Asada Y. The ideal of equal health revisited: Definitions and
measures of inequity in health should be better integrated with theories of
distributive justice. Int J Equity Health. 2009;8:40. http://www.equityhealthj.
com/content/8/1/40.
15. O'Donnell O, van Doorslaer E, Wagstaff A, Lindelow M. Analyzing health
equity using household survey data: A guide to techniques and their
implementation. New York: The World Bank; 2007.
16. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI):
concepts, measurement properties and applications. Health Qual Life
Outcomes. 2003;1:1–13. http://www.hqlo.com/content/pdf/1477-7525-1-54.pdf.
17. Drummond M. Introducing economic and quality of life measurements into
clinical studies. Ann Med. 2001;33:344–9.
18. Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D.
Determining clinically important differences in health status measures.
Pharmacoeconomics. 1999;15:141–55.
19. Chen C-N, Tsaur T-W, Rhai T-S. The Gini coefficient and negative income.
Oxf Econ Pap. 1982;34:473–8.
20. Harper S, Lynch J. Methods for measuring cancer disparities: using data
relevant to Healthy People 2010 cancer-related objectives. NCI Cancer
Surveill Monogr Ser. 2005;6:05–5777. http://seer.cancer.gov/archive/publications/
disparities/. Accessed 18 Jan 2015.
21. Smits J, Monden C. Length of life inequality around the globe. Soc Sci Med.
2009;68:1114–23.
22. Atkinson AB. Health inequality, health inequity and health spending. In: Eyal
N, Hurst S, Norheim OF, Wikler D, editors. Inequalities in health: concepts,
measures, and ethics. New York: Oxford University Press; 2013. p. 27–36.
23. Huang IC, Frangakis C, Atkinson MJ, Willke RJ, Leite WL, Vogel WB, et al.
Addressing ceiling effects in health status measures: a comparison of
Asada et al. International Journal for Equity in Health  (2015) 14:11 Page 12 of 12techniques applied to measures for people with HIV disease. Health Serv
Res. 2008;43:327–39.
24. Li L, Fu AZ. Some methodological issues with the analysis of preference-based
EQ-5D index score. Health Serv Outcomes Res Methodol. 2009;9:162–76.
25. Pullenayegum EM, Tarride JE, Xie F, Goeree R, Gerstein HC, O'Reilly D.
Analysis of health utility data when some subjects attain the upper bound
of 1: are Tobit and CLAD models appropriate? Value Health. 2010;13:487–94.
26. Sullivan PW, Ghushchyan V. Mapping the EQ-5D index from the SF-12: US
general population preferences in a nationally representative sample. Med
Decis Making. 2006;26:401–9.
27. Araar A, Duclos J. DASP: Distributive Analysis Stata Package. Universite Lavel,
PEP, CIRPEE and World Bank; 2012. http://dasp.ecn.ulaval.ca. Accessed 18
Jan 2015.
28. StataCorp. Stata statistical software: release 11.0. College Station, Texas: Stata
Corporation; 2009.
29. Eng K, Feeny D. Comparing the health of low income and less well
educated groups in the United States and Canada. Popul Health Metr.
2007;5:10. http://www.biomedcentral.com/content/pdf/1478-7954-5-10.pdf.
30. McGrail KM, van Doorslaer E, Ross NA, Sanmartin C. Income-related health
inequalities in Canada and the United States: a decomposition analysis. Am
J Public Health. 2009;99:1856–63.
31. Gordis L. Epidemiology. Philadelphia: W.B. Saunders Company; 1996.
32. Cappelen AW, Norheim OF, Tungodden B. Genomics and equal opportunity
ethics. J Med Ethics. 2008;34:361–4.
33. Dworkin R. What is equality? Part 1: Equality of welfare. Philosophy Public
Affairs. 1981;10:185–246.
34. Dworkin R. What is equality? Part 2: Equality of resources. Philosophy Public
Affairs. 1981;10:283–345.
35. Hausman D. Egalitarian critiques of health inequalities. In: Eyal N, Hurst S,
Norheim OF, Wikler D, editors. Inequalities in health: concepts, measures,
and ethics. New York: Oxford University Press; 2013. p. 95–112.
36. Marmot M. Fair society, healthy lives. In: Eyal N, Hurst S, Norheim OF, Wikler
D, editors. Inequalities in health: concepts, measures, and ethics. New York:
Oxford University Press; 2013. p. 282–98.
37. Segall S. Health, luck, and justice. Princeton: Princeton University Press; 2010.
38. Anderson ES. What is the point of equality? Ethics. 1999;109:287–337.
39. Bago d'Uva T, Jones AM, van Doorslaer E. Measurement of horizontal
inequity in health care utilisation using European panel data. J Health Econ.
2009;28:280–9.
40. Deaton A. What does the empirical evidence tell us about the injustice of
health inequalities? In: Eyal N, Hurst S, Norheim OF, Wikler D, editors.
Inequalities in health: concepts, measures, and ethics. New York: Oxford
University Press; 2013. p. 263–381.
41. Temkin L. Rethinking the good: moral ideals and the nature of practical
reasoning. New York: Oxford University Press; 2013.
42. Lefranc A, Pistolesi N, Trannoy A. Equality of opportunity and luck:
Definitions and testable conditions, with an application to income in
France. J Public Econ. 2009;93:1189–207.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
